Home > Financial Ratios > SOTAC PHARMACEUTICALS

SOTAC PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
AD     Remove this Ad

SOTAC PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 99.2114.8319.94309.00-25.23

What is the latest Core EBITDA Growth ratio of SOTAC PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of SOTAC PHARMACEUTICALS is 99.21 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202599.21
Mar202414.83
Mar202319.94
Mar2022309.00
Mar2021-25.23

How is Core EBITDA Growth of SOTAC PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 99.21
568.98
Mar2024 14.83
-25.63
Mar2023 19.94
-93.55
Mar2022 309
Positive
Mar2021 -25.23 -

Other Financial Ratios of SOTAC PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of SOTAC PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS ₹127.7 Cr 3.6% -6.8% -17.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,645.0 Cr 2.9% 3.6% 0.2% Stock Analytics
DIVIS LABORATORIES ₹159,625.0 Cr 0.6% -4.5% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,415.0 Cr 2.1% -0.4% 31.8% Stock Analytics
DR REDDYS LABORATORIES ₹108,664.0 Cr 2.2% -0.4% 6.2% Stock Analytics
CIPLA ₹100,480.0 Cr 0.4% -6.2% -19.4% Stock Analytics


SOTAC PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS

3.6%

-6.8%

-17.9%

SENSEX

-1.9%

-9.1%

-0.2%


You may also like the below Video Courses